Nuvalent, Inc.
NUVL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $217,774 | $113,243 | $63,731 | $35,559 |
| G&A Expenses | $62,594 | $36,249 | $22,377 | $10,258 |
| SG&A Expenses | $62,594 | $36,249 | $22,377 | $10,258 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $280,368 | $149,492 | $86,108 | $45,817 |
| Operating Income | -$280,368 | -$149,492 | -$86,108 | -$45,817 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $20,376 | $23,273 | $4,254 | -$521 |
| Pre-Tax Income | -$259,992 | -$126,219 | -$81,854 | -$46,338 |
| Tax Expense | $764 | $0 | $0 | $0 |
| Net Income | -$260,756 | -$126,219 | -$81,854 | -$46,338 |
| % Margin | – | – | – | – |
| EPS | -3.93 | -2.17 | -1.65 | -2.13 |
| % Growth | -81.1% | -31.5% | 22.5% | – |
| EPS Diluted | -3.93 | -2.17 | -1.65 | -2.13 |
| Weighted Avg Shares Out | 66,409 | 58,223 | 49,669 | 21,783 |
| Weighted Avg Shares Out Dil | 66,409 | 58,223 | 49,669 | 21,784 |
| Supplemental Information | – | – | – | – |
| Interest Income | $38,316 | $23,273 | $0 | $0 |
| Interest Expense | $0 | $23,273 | $0 | $0 |
| Depreciation & Amortization | $280,368 | $0 | $0 | $0 |
| EBITDA | $0 | -$126,219 | -$86,108 | -$45,817 |
| % Margin | – | – | – | – |